Nathalie Clément

Medicine · Health Sciences

39h-index4.3kcitations177works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(55), Virus-based gene therapy research(44), Cancer, Hypoxia, and Metabolism(22), Viral Infectious Diseases and Gene Expression in Insects(18), Cancer Genomics and Diagnostics(14)

Publications177 total

Differential effects of voriconazole and posaconazole on macrophage antifungal activity against Scedosporium apiospermum
SSRN Electronic Journal·2026Open Access
AAV downstream challenges: specialist insights
Cell and Gene Therapy Insights·2024
Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy
Cell and Gene Therapy Insights·2024
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy
UNC Libraries·2024Open Access
Use of Herbal Medicine in French Guiana: Influences and Challenges for Prevention Strategies in the Context of the COVID-19 Pandemic
Journal of Herbal Medicine·2024· 1 citedOpen Access
Vaccination Covid-19
International Journal of Integrated Care·2023Open Access
The comparability tales: A phase-appropriate roadmap for CGT drug product development
Molecular Therapy — Methods & Clinical Development·2023Open Access
Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France
Open Forum Infectious Diseases·2023· 16 citedOpen Access
Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation
Molecular Therapy — Methods & Clinical Development·2023· 26 citedOpen Access
Supplemental Figure 3 from Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
2023Open Access
Supplementary Table 3 from Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma
2023Open Access
Supplementary Table 2 from Deep Sequencing Reveals Occurrence of Subclonal <i>ALK</i> Mutations in Neuroblastoma at Diagnosis
2023Open Access
Supplementary Figure 2 from Deep Sequencing Reveals Occurrence of Subclonal <i>ALK</i> Mutations in Neuroblastoma at Diagnosis
2023Open Access
Data from Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
2023Open Access
Supplemental Figure 5 from Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
2023Open Access
Supplementary Table 2 from Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma
2023Open Access
Supplemental Figure 4 from Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
2023Open Access
Supplemental Figure 3 from Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
2023Open Access
Supplementary Table 1 from Deep Sequencing Reveals Occurrence of Subclonal <i>ALK</i> Mutations in Neuroblastoma at Diagnosis
2023Open Access
Supplementary Table 1 from Deep Sequencing Reveals Occurrence of Subclonal <i>ALK</i> Mutations in Neuroblastoma at Diagnosis
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Barry J. Byrne(17), Gudrun Schleiermacher(10), Brian Cleaver(9), Gaëlle Pierron(9), Virginie Bernard(8), Eve Lapouble(8), Olivier Delattre(8), Jean‐Luc Guillaume(7), Ralf Jockers(7), Thomas J. Conlon(7), Valérie Combaret(7), Manuela Corti(7), R. Michael Linden(7), Darin J. Falk(7), Cathryn Mah(6), Angela Bellini(6), Barbara K. Smith(5), David D. Fuller(5), Mathieu Chicard(5), Léo Colmet‐Daage(5)